Table 3

Subgroup survival analysis

VariablesnUnivariate HR
(95% CI, p value)
Multivariate HR
(95% CI, p value)
StateNSW+ACT165611
QLD9551.08 (0.93 to 1.26, p=0.314)1.07 (0.91 to 1.25, p=0.410)
SA5350.94 (0.77 to 1.14, p=0.506)1.05 (0.86 to 1.29, p=0.632)
TAS991.45 (1.02 to 2.06, p=0.040)1.43 (1.00 to 2.04, p=0.00.05)
VIC10660.69 (0.58 to 0.82, p<0.001)0.73 (0.61 to 0.87, p<0.001)
WA4061.33 (1.10 to 1.61, p=0.004)1.37 (1.13 to 1.71, p=0.001)
Age<60198911
≥6027281.68 (1.49 to 1.89, p<0.001)1.70 (1.51 to 1.92, p<0.001)
SexFemale223911
Male24781.00 (0.89 to 1.12, p=0.997)1.01 (0.90 to 1.13, p=0.863)
Histology8720—Melanoma, NOS314411
8770—Mixed cell5362.07 (1.77 to 2.41, p<0.001)2.00 (1.71 to 2.35, p<0.001)
8771—Epithelioid cell1272.51 (1.89 to 3.33, p<0.001)2.30 (1.72 to 3.07, p<0.001)
8772—Spindle cell, NOS2911.05 (0.82 to 1.33, p=0.717)1.06 (0.83 to 1.36, p=0.640)
8773—Spindle A cell580.42 (0.20 to 0.88, p=0.021)0.39 (0.18 to 0.81, p=0.013)
8774—Spindle B cell5611.04 (0.87 to 1.25, p=0.651)1.03 (0.85 to 1.24, p=0.799)
  • Significant values have been bolded.

  • ACT, Australian Capital Territory; NOS, not otherwise specified; NSW, New South Wales; NT, Northern Territory; QLD, Queensland; SA, South Australia; TAS, Tasmania; VIC, Victoria; WA, Western Australia.